Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of the project is to set up a national, prospective, longitudinal, multicenter registry platform to document uniform data on characteristics, molecular diagnostics, treatment and course of disease, to collect patient-reported outcomes and to establish a decentralized biobank for patients with hematological malignancies in Germany.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek minimum 18 lat
- •Potwierdzowana diagnoza chłoniaka lub białaczki
- •Dla żyjących pacjentów: podpisana zgoda na uczestnictwo w badaniu
- •Zgoda powinna być udzielona przed lub w dniu rozpoczęcia leczenia, lub najpóźniej 8 tygodni po jego rozpoczęciu
✗ Disqualifies
- •Brak leczenia chemioterapią lub inną terapią systemową dla danej choroby nowotworowej
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 13, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Praxis für Interdisziplinäre Hämatologie und Onkologie
Freiburg im Breisgau, Germany
Trial contact
Martina Jänicke, Dr.
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/14/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.